• 제목/요약/키워드: Gamma-knife radiosurgery

검색결과 126건 처리시간 0.028초

Quantitative Feasibility Evaluation of 11C-Methionine Positron Emission Tomography Images in Gamma Knife Radiosurgery : Phantom-Based Study and Clinical Application

  • Lim, Sa-Hoe;Jung, Tae-Young;Jung, Shin;Kim, In-Young;Moon, Kyung-Sub;Kwon, Seong-Young;Jang, Woo-Youl
    • Journal of Korean Neurosurgical Society
    • /
    • 제62권4호
    • /
    • pp.476-486
    • /
    • 2019
  • Objective : The functional information of $^{11}C$-methionine positron emission tomography (MET-PET) images can be applied for Gamma knife radiosurgery (GKR) and its image quality may affect defining the tumor. This study conducted the phantom-based evaluation for geometric accuracy and functional characteristic of diagnostic MET-PET image co-registered with stereotactic image in Leksell $GammaPlan^{(R)}$ (LGP) and also investigated clinical application of these images in metastatic brain tumors. Methods : Two types of cylindrical acrylic phantoms fabricated in-house were used for this study : the phantom with an array-shaped axial rod insert and the phantom with different sized tube indicators. The phantoms were mounted on the stereotactic frame and scanned using computed tomography (CT), magnetic resonance imaging (MRI), and PET system. Three-dimensional coordinate values on co-registered MET-PET images were compared with those on stereotactic CT image in LGP. MET uptake values of different sized indicators inside phantom were evaluated. We also evaluated the CT and MRI co-registered stereotactic MET-PET images with MR-enhancing volume and PET-metabolic tumor volume (MTV) in 14 metastatic brain tumors. Results : Imaging distortion of MET-PET was maintained stable at less than approximately 3% on mean value. There was no statistical difference in the geometric accuracy according to co-registered reference stereotactic images. In functional characteristic study for MET-PET image, the indicator on the lateral side of the phantom exhibited higher uptake than that on the medial side. This effect decreased as the size of the object increased. In 14 metastatic tumors, the median matching percentage between MR-enhancing volume and PET-MTV was 36.8% on PET/MR fusion images and 39.9% on PET/CT fusion images. Conclusion : The geometric accuracy of the diagnostic MET-PET co-registered with stereotactic MR in LGP is acceptable on phantom-based study. However, the MET-PET images could the limitations in providing exact stereotactic information in clinical study.

해면상 혈관종의 자연 경과와 치료 전략 (Cavernous Angioma : Natural History and Management Strategies)

  • 임효주;권양;안재성;김정훈;김창진;이정교;권병덕
    • Journal of Korean Neurosurgical Society
    • /
    • 제29권8호
    • /
    • pp.1001-1007
    • /
    • 2000
  • Objective : We analysed diverse clinical features of the cavernous angioma. Also, we report the experience in differ-ent methods of the management and their results. Method : Data from 80 patients who were confirmed pathologically or diagnosed radiologically between Jan. 1990 and Sept. 1998 at our hospital were analysed. Variable factors that were examined were : clinical features, effects of treatment, and complications. Results : There were 47 male and 33 female patients. The age at the first presentation was from 3 to 57(mean 34.1) years old. Clinical features were seizure in 28 cases(38%), bleeding in 24 cases(32%), neurologic deficits in 12 cases(16%), headache in 10 cases(14%), and six incidental cases. The locations of lesion were cerebral and cerebellar hemisphere in 45 cases(56.2%), brainstem, basal ganglia, and thalamus in 32 cases(40%), multiple in 3 cases (3.8%). Seizure was common at the third decade and occurred frequently with the cavernous angioma in temporal (43%) or frontal lobe(39%). Bleeding was frequent after the third decade with peak at the fourth decade and had high incidence in brainstem or thalamus. The gamma-knife radiosurgery was done in 47 cases. Rebleeding occurred in 3 cases, but it was within postradiosurgery 1 year. Symptomatic radiation change occurred in 2 cases of 8 radiation change on MRI. On follow-up MRI, no evidence of rebleeding was found in 30 cases. Also, The lesion size was decreased in 3 cases. Resection was performed in 23 cases ; total 20, subtotal 2, partial 1. Postoperative complication occurred in 6 cases(26.1%). After surgery, 7(63.6%) of 11 seizure patients had outcome of seizure-free. Subclinical rebleeding occurred in one of two subtotal resected cases. In 11 patients, conservative management was done. There was neither rebleeding nor symptom aggravation during follow-up period of mean 17.2 months. Conclusion : The solution for prevention of rebleeding is complete removal of the lesion located at noneloquent area or accessible region, especially for the patients who presented symptoms or intractable seizure. However, the Gamma knife radiosurgery is considered when the lesions are located at eloquent area or when severe postoperative morbidity is expected.

  • PDF

다양한 Plugging 형태를 이용한 감마나이프의 선택적 빔 차폐 방법 (Selective Beam Shielding Method of Gamma-Knife Unit Using Various Plugging Patterns)

  • 장건호;임영진;신동오;최두호;홍성언;임언
    • Radiation Oncology Journal
    • /
    • 제11권2호
    • /
    • pp.439-448
    • /
    • 1993
  • Leksell 감마나이프(B-형)가 1992년 3월 경희대학교 의과대학 병원에 설치되었다. 선택적 빔 Plugging방법을 이용하여 정상 민감 조직에 대한 저선량 분포를 현저히 줄일 수 있으며, 또한 치료 부위에 더 좋은 선량 분포를 얻을 수 있다. 저선량에 대한 여러가지 선량 분포의 변화에 대한 연구를 하였으며, 사용중인 KULA프로그램의 선량 분포 곡선을 평가하기 위해 필름을 이용한 방사선량 계측을 실시하였고, RFA-3자동 밀도 측정기를 이용하여 평가하였다. 1992년 3월부터 1993년 2월까지 1년동안 100명의 환자중 17명의 환자에 선택적 빔 차폐 방법이 적용되었다. 고선량 영역에서는 측정값과 프로그램에서 제공된 선량 분포가 잘 일치하였다. 뇌하수체 선종의 치료시 치료 부위가 클 경우에는 본 연구 방법의 적용이 매우 중요시 되었으며, 반면에 치료 영역이 작을 경우에는 적절한 헬맷의 선택이 중요함을 알 수 있었다. 치료 환자의 중요 민감 장기의 방사선 선량 평가에서는 뇌간에 3~12 Gy, 시신경 교차에 3~11.2 Gy이었다. 중추신경계 영역의 최적화된 치료를 위하여 다양한 Plugging형태를 임상에 적용하는 것이 방사선에 민감한 정상 조직을 보호하기 위해 매우 중요한 인자가 됨을 알았다.

  • PDF

The Role of Radiosurgery in Patients with Brain Metastasis from Small Cell Lung Carcinoma

  • Jo, Kwang-Wook;Kong, Doo-Sik;Lim, Do-Hoon;Ahn, Yong-Chan;Nam, Do-Hyun;Lee, Jung-Il
    • Journal of Korean Neurosurgical Society
    • /
    • 제50권2호
    • /
    • pp.99-102
    • /
    • 2011
  • Objective : The purpose of this retrospective study was to evaluate the outcome of gamma knife radiosurgery (GKRS) and/or whole brain radiation therapy (WBRT) for the treatment of small cell lung carcinoma (SCLC) metastasis to the brain. Methods : From 2000 to 2010, 50 patients underwent GKRS for metastatic brain lesions originating from SCLC. Among these patients, 11 received prophylactic cranial irradiation (PCI) before the development of metastatic lesions (PCI group), and GKRS was performed as an initial treatment for newly diagnosed lesions in 12 patients who had not received PCI (primary GKRS group). In addition, GKRS was performed as a salvage treatment for progressive lesions after WBRT in 27 patients (salvage GKRS group). The medical records and imaging data of all patients were retrospectively analyzed. Results : The overall survival of the 50 patients was 20.8 months (range 1-53) after the diagnosis of primary tumor and 12.0 months (range 1-47) after the development of cerebral metastasis. Median survival after GKRS was 4.8 months (range 1-15) in the PCI group, 4.6 months (range 0-18) in the primary GKRS group, and 7.6 months (range 0-33) in the salvage GKRS group. Further treatment for progressive lesions after GKRS was necessary in 15 patients, after a mean interval of 3.8 months. Causes of death were systemic organ failure in 15 patients, deterioration of neurological state in 13 patients, and unknown or combined causes in 16 patients. The local control rate of the lesions treated with GKRS was 76.4% (decreased in 13 patients and stable in 16 patients at the final imaging follow-up (mean 5.60 months). Conclusion : GKRS is an effective local treatment for brain metastasis from SCLC both as an initial treatment for newly diagnosed lesions after PCI and as a salvage treatment for recurrent or progressive lesions. However, the survival benefit is not significant because most patients die of systemic multi-organ failure with a short life expectancy.

선형 가속기를 이용한 정위적 방사선 수술시 병소내 선량분포의 특성조사 (Search of Characteristic for Dose Distribution Presented by Multi­isocentric Stereotactic Radiosurgical Plan Using Linear Accelerator)

  • 최경식;오승종;이형구;최보영;전흥재;서태석
    • 한국의학물리학회지:의학물리
    • /
    • 제14권4호
    • /
    • pp.225-233
    • /
    • 2003
  • 방사선 치료 계획의 목적은 정상 조직 부근에서는 최소한의 방사선 조사가 되는 동안 병소에는 동일한 선량이 조사되는 것이다. 선형가속기를 이용한 정위적 방사선 수술시 단일한 구형의 선량분포는 병소에 대하여 균등한 선량분포를 이루고, 병소 내에는 70% 이상의 고선량이 등선량 곡선내에 포함되면서 주위 정상조직에서는 급격히 낮은 선량을 가지게 한다. 또한 이와 같은 방법은 감마나이프를 이용한 정위적 방사선 수술의 경우와 비슷한 치료 계획을 나타낸다. 이처럼 정위적 방사선 수술시 이용되는 구형의 선량분포를 가지는 isocenter는 실제 방사선 수술 계획시 많은 시간과 경험을 바탕으로 수술 계획자에 의해 병소 내에 배치되어 진다. 본 연구는 효율적인 방사선 수술이 수행되도록 수술 계획시 구형 선량분포에 관여하는 빔관련 변수들을 고려하여 병소내 선량분포의 특성을 조사하였다. 이를 위해 불규칙한 형태의 병소를 직육면체형과 원통형으로 가정하여 비교하였고, 동일한 체적의 병소 모델에 대하여 빔관련 변수를 변화시켜 구형 선량분포를 이루는 isocenter들의 위치 및 콜리메이터의 크기를 달리하면서 병소 모델에 대한 선량 분포를 얻었다. 이때, 얻어진 선량분포 Dose Profile과 Dose Volume Histogram (DVH)으로 비교한 결과, 불규칙한 모양의 병소에 대하여 콜리메이터의 크기와 Isocenter의 개수, Isocenter의 간격 등의 빔관련 변수를 최적화함으로서 더 나은 고선량의 등선량 곡선(Isodose Curve)내에 병소를 포함시킬 수 있었다. 이러한 병소내 구형 선량 분포를 가지는 isocenter의 배치에 따른 특성들은 정위적 방사선 수술 계획시 더 효율적이면서, 빠른 수술 계획을 수립하는데 많은 도움이 될 것으로 사료된다.

  • PDF

The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery

  • Lee, Min Ho;Kong, Doo-Sik;Seol, Ho Jun;Nam, Do-Hyun;Lee, Jung-Il
    • Journal of Korean Neurosurgical Society
    • /
    • 제60권1호
    • /
    • pp.21-29
    • /
    • 2017
  • Objective : The purpose of this study was to analyze outcomes and identify prognostic factors in patients with cerebral metastases from non-small cell lung cancer (NSCLC) treated with gamma knife radiosurgery (GKS) particularly, focusing on associations of biomarkers and systemic treatments. Methods : We retrospectively reviewed the medical records of 134 patients who underwent GKS for brain metastases due to NSCLC between January 2002 and December 2012. Representative biomarkers including epidermal growth factor receptor (EGFR) mutation, K-ras mutation, and anaplastic lymphoma kinase (ALK) mutation status were investigated. Results : The median overall survival after GKS was 22.0 months (95% confidence interval [CI], 8.8-35.1 months). During follow-up, 63 patients underwent salvage treatment after GKS. The median salvage treatment-free survival was 7.9 months (95% CI, 5.2-10.6 months). Multivariate analysis revealed that lower recursive partition analysis (RPA) class, small number of brain lesions, EGFR mutation (+), and ALK mutation (+) were independent positive prognostic factors associated with longer overall survival. Patients who received target agents 30 days after GKS experienced significant improvements in overall survival and salvage treatment-free survival than patients who never received target agents and patients who received target agents before GKS or within 30 days (median overall survival: 5.0 months vs. 18.2 months, and 48.0 months with p-value=0.026; median salvage treatment-free survival: 4.3 months vs. 6.1 months and 16.6 months with p-value=0.006, respectively). To assess the influence of target agents on the pattern of progression, cases that showed local recurrence and new lesion formation were analyzed according to target agents, but no significant effects were identified. Conclusion : The prognosis of patients with brain metastases of NSCLC after GKS significantly differed according to specific biomarkers (EGFR and ALK mutations). Our results show that target agents combined with GKS was related to significantly longer overall survival, and salvage treatment-free survival. However, target agents were not specifically associated with improved local control of the lesion treated by GKS either development of new lesions. Therefore, it seems that currently popular target agents do not affect brain lesions themselves, and can prolong survival by controlling systemic disease status.

Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery

  • Lee, Min Ho;Cho, Kyung-Rae;Choi, Jung Won;Kong, Doo-Sik;Seol, Ho Jun;Nam, Do-Hyun;Jung, Hyun Ae;Sun, Jong-Mu;Lee, Se-Hoon;Ahn, Jin Seok;Ahn, Myung-Ju;Park, Keunchil;Lee, Jung-Il
    • Journal of Korean Neurosurgical Society
    • /
    • 제64권2호
    • /
    • pp.271-281
    • /
    • 2021
  • Objective : Immune checkpoint inhibitors (ICIs) are approved for treating non-small-cell lung cancer (NSCLC); however, the safety and efficacy of combined ICI and Gamma Knife radiosurgery (GKS) treatment remain undefined. In this study, we retrospectively analyzed patients treated with ICIs with or without GKS at our institute to manage patients with brain metastases from NSCLC. Methods : We retrospectively reviewed medical records of patients with brain metastases from NSCLC treated with ICIs between January 2015 and December 2017. Of 134 patients, 77 were assessable for brain responses and categorized into three groups as follows : group A, ICI alone (n=26); group B, ICI with concurrent GKS within 14 days (n=24); and group C, ICI with non-concurrent GKS (n=27). Results : The median follow-up duration after brain metastasis diagnosis was 19.1 months (range, 1-77). At the last follow-up, 53 patients (68.8%) died, 20 were alive, and four were lost to follow-up. The estimated median overall survival (OS) of all patients from the date of brain metastasis diagnosis was 20.0 months (95% confidence interval, 12.5-27.7) (10.0, 22.5, and 42.1 months in groups A, B, and C, respectively). The OS was shorter in group A than in group C (p=0.001). The intracranial disease progression-free survival (p=0.569), local progression-free survival (p=0.457), and complication rates did not significantly differ among the groups. Twelve patients showed leptomeningeal seeding (LMS) during follow-up. The 1-year LMS-free rate in treated with ICI alone group (69.1%) was significantly lower than that in treated with GKS before ICI treatment or within 14 days group (93.2%) (p=0.004). Conclusion : GKS with ICI showed no favorable OS outcome in treating brain metastasis from NSCLC. However, GKS with ICI did not increase the risk of complications. Furthermore, compared with ICI alone, GKS with ICI may be associated with a reduced incidence of LMS. Further understanding of the mechanism, which remains unknown, may help improve the quality of life of patients with brain metastasis.

로봇 사이버나이프에서 위치인식시스템을 이용한 Targeting Error값 보정의 정확성 평가 (Evaluation on the Accuracy of Targeting Error Correction Through the Application of Target Locating System in Robotic CyberKnife)

  • 정영준;정재홍;임광채;조은주
    • 대한방사선치료학회지
    • /
    • 제21권1호
    • /
    • pp.1-7
    • /
    • 2009
  • 목 적: 로봇 사이버나이프에서 환자의 움직임에 의한 기준점의 위치변화 오차가 위치인식시스템(target location system, TLS) 을 통하여 targeting error값이 정확히 보정(correction)되는지 평가하고자 한다. 대상 및 방법: 본 실험은 targeting의 정확성을 분석하기 위해 head and neck팬텀에 Gafchromic 필름(MD-55)을 삽입한 후, 사이버나이프(CyberKnife Robotic Radiosurgery System G4, Accuray, US)의 6 MV X선을 조사하였다. 필름 분석은 Accuray사에서 제공하는 End to End (E2E) 프로그램을 이용하였다. 기준점의 위치에서 x, y, z방향으로 $0{\pm}0.2\;mm$, roll, pitch, yaw방향으로 $0{\pm}0.2^{\circ}$ 이내로 유지하여 12회 조사한 대조군과 인위적으로 움직임을 주어 실험을 시행한 6회의 실험군의 targeting 오차를 구하고, 대조군과 실험군의 평균값에 대한 유의성을 t-검정을 통해 분석하였다. 또한, gamma-index method (dose difference: 3%)를 통해 2차원적 선량분포의 일치성을 distance to agreement (DTA)를 각각 1 mm, 1.5 mm, 2 mm로 달리하여 정량화하고, 비교 분석하였다. 결 과: E2E test 시행 결과, 기준 필름의 targeting 평균오차 0.405 mm, 표준편차 0.069 mm, 실험 필름의 평균오차 0.413 mm, 표준편차 0.121 mm으로 나왔으며, t-검정 결과 유의확률 P=0.836 (신뢰구간 95%)으로 두 집단에서 유의한 차이를 볼 수 없었다. 또한, DTA를 각각 1 mm, 1.5 mm, 2 mm로 선량분포의 일치성을 비교한 결과 기준필름 3,314개 위치에서 axial필름 평균은 각각 95.04%, 97.56%, 98.13%, sagittal필름 평균은 각각 95.47%, 97.68%, 98.47% 일치하였다. 실험필름과 비교한 결과 3,323개 위치에서 axial필름 평균은 각각 96.38%, 97.57%, 98.04%, sagittal필름 평균은 각각 95.50%, 97.87%, 98.36% 일치하는 것을 확인할 수 있었다. 결 론: 로봇 사이버나이프는 치료 시 환자의 움직임에 의해 발생하는 기준점의 위치변화 오차를 실시간 추적하여 보정하며, targeting 오차를 1 mm 이내, 선량분포는 95% 이상 일치하는 정확성을 확인할 수 있었다.

  • PDF

감마나이프 방사선수술 치료계획의 평가에 필수불가결한 지표들의 분석 (Analyses of the indispensible Indices in Evaluating Gamma Knife Radiosurgery Treatment Plans)

  • 허병익
    • 한국방사선학회논문지
    • /
    • 제11권5호
    • /
    • pp.303-312
    • /
    • 2017
  • 감마나이프 방사선수술(GKRS)의 핵심 목표는 병변에 처방 등선량 표면의 일치성을 최대화하고 병변 주변부 정상 조직의 방사선 효과를 최소화하는 것이다. 일치성 지표, 적용 범위, 선택성, 빔-온 시간, 기울기 지표(GI), 일치성/기울기 지표(CGI)와 같은 치료계획의 질과 관련된 다양한 종류의 지표들이 존재한다. 이 가운데 최상의 치료계획 평가 도구로서 우리는 일치성 지표, GI 및 CGI를 반드시 확인해야 한다. 특히 건강한 정상조직의 합병증과 관련된 GI 및 CGI는 일치성 지표보다 더욱더 중요하게 여겨진다. 그래서 저자는 치료계획 시스템 렉셀 감마플랜(LGP) 및 검증 방법 가변 타원체 모형화 기술(VEMT)을 사용하여 광범위하게 적용되고 있는 GI 뿐 만 아니고 CGI, 새로이 정의된 일치성/기울기 지표를 계산하고 통계적으로 분석하였다. 본 연구는 GKRS로 치료받은 두개 내 병변을 가진 10명의 환자를 대상으로 하였다. 저자는 단지네 인자들: 처방 등선량 체적, 최대 선량의 30% 이상 체적, 병변 체적, 처방 등선량 절반의 체적 만을 가지고 LGP와 VEMT를 이용해서 지표를 계산했다. 모든 데이터는 두 가지 다른 측정기법을 비교하는데 사용되는 통계적 방법인 Paired t-test로 분석되었다. 10명의 사례에서 LGP와 VEMT 사이에 GI의 통계적 유의성은 관찰되지 않았다. GI의 차이는 -0.14에서 0.01 사이의 범위였다. LGP와 VEMT의 두 가지 방법으로 계산된 새롭게 정의된 기울기 지표 또한 통계적으로 유의하지 않았다. 저자는 LGP와 VEMT 사이에 처방 등선량 체적에 대한 통계적 차이를 발견하지 못했다. 최상의 치료계획을 결정하기 위한 또 하나의 평가 지표인 CGI도 통계적으로 유의하지 않았고 CGI의 차이는 -4에서 3까지 이었다. 똑같이 GKRS에 적합하게 새로이 정의된 일치성/기울기 지표도 통계 분석을 통해서 치료계획 평가를 위한 훌륭한 측정 기준으로 여겨진다. 통계분석 결과 VEMT는 GKRS에서 최상의 치료계획을 평가하기 위해 GI, 새로운 기울기 지표, CGI 및 새로운 CGI를 고려했을 때 LGP와 우수한 일치를 보였다. 저자는 LGP 및 VEMT를 통해서 빠르고 쉬운 평가도구의 적용성으로 인하여 GI 뿐 만 아니라 CGI와 새로이 정의된 CGI가 널리 사용되기를 기대한다.

A patient who has survived for a long period with repeated radiotherapies for multifocal extrahepatic metastases from hepatocellular carcinoma

  • Jo, Sunmi;Shim, Hye Kyung
    • Radiation Oncology Journal
    • /
    • 제31권4호
    • /
    • pp.267-272
    • /
    • 2013
  • Although significant advances in the treatment of intrahepatic lesions, it is reported that the prognosis for patients with hepatocellular carcinoma (HCC) who have extrahepatic metastasis remains poor. We report a patient with lung, liver, brain, bone and subcutaneous metastasis from HCC who has survived more than 7 years maintaining relatively good performance status as a result of repeated therapies. A 55-year-old male patient with HCC underwent right lobectomy of the liver and cholecystectomy in September 2006. He received wedge resection for lung metastasis twice (July 2009, January 2011) and Gamma Knife stereotactic radiosurgery for brain metastasis (April 2011). Over the last 3 years, he has developed metastasis in subcutaneous tissues, muscle, and bone with pain. He has undergone 7 courses of radiotherapies for subcutaneous tissues, muscle, and bone metastasis and been prescribed sorafenib and he is still capable of all self-care.